Sanaria Incis A Biotechnology Company Located In Rockvillemarylandfounded In 2003 By Stephen Lhoffmanthe Company Is Focused On Developing Innovative Vaccinesparticularly Targeting Malariasanaria Aims To Create Whole Parasite Vaccines That Provide Long Lasting Protection Againstplasmodium Falciparum The Main Cause Of Severe Malaria Cases And Deaths Worldwide The Company S Primary Product Is The Pfspz Vaccine Seriesincluding The Sanariaapfspz Larc2 Vaccinewhich Is Designed To Offer High Level Protection Against Malaria With A Single Dosein Addition To Malaria Vaccinessanaria Is Also Working On Monoclonal Antibodies Against Malariavaccines For Diarrheal Diseasesand Immunotherapeutics For Liver Diseasestheir Vaccines Are Intended For High Risk Populationssuch As Pregnant Women And Children In Malaria Endemic Areasas Well As Travelers To These Regionssanaria Has Collaborated With Various Research Institutions To Advance Its Vaccine Development Efforts And Has Been Recognized For Its Contributions To Tropical Medicine
